Purpose
LITE2.0 TALE-CIB1. Changes from LITE1.0: glycine-serine linker, mutated endogenous NLS, aa318-334 deletion. This particular TALE targeted to Neurog2. EF1-alpha promoter for ubiquitous mammalian exp.
Insert
TALE (Neurog2)-GS-CIB1(NLS*,∆318-334)
Available Since
Oct. 22, 2013
Availability
Academic Institutions and Nonprofits only